A detailed history of Revolve Wealth Partners, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Revolve Wealth Partners, LLC holds 6,640 shares of DXCM stock, worth $483,591. This represents 0.07% of its overall portfolio holdings.

Number of Shares
6,640
Previous 2,145 209.56%
Holding current value
$483,591
Previous $243,000 83.13%
% of portfolio
0.07%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$64.0 - $116.06 $287,680 - $521,689
4,495 Added 209.56%
6,640 $445,000
Q2 2024

Jul 19, 2024

SELL
$110.31 - $140.45 $7,721 - $9,831
-70 Reduced 3.16%
2,145 $243,000
Q1 2024

Apr 15, 2024

BUY
$114.22 - $140.1 $7,881 - $9,666
69 Added 3.22%
2,215 $307,000
Q4 2023

Jan 12, 2024

SELL
$75.49 - $124.16 $10,266 - $16,885
-136 Reduced 5.96%
2,146 $266,000
Q3 2023

Oct 10, 2023

SELL
$86.06 - $137.93 $14,113 - $22,620
-164 Reduced 6.7%
2,282 $212,000
Q2 2023

Jul 20, 2023

BUY
$112.47 - $130.98 $13,271 - $15,455
118 Added 5.07%
2,446 $314,000
Q1 2023

Apr 06, 2023

SELL
$104.0 - $122.92 $18,512 - $21,879
-178 Reduced 7.1%
2,328 $270,000
Q4 2022

Jan 17, 2023

SELL
$84.98 - $122.67 $17,335 - $25,024
-204 Reduced 7.53%
2,506 $0
Q3 2022

Oct 12, 2022

SELL
$76.35 - $94.18 $12,292 - $15,162
-161 Reduced 5.61%
2,710 $218,000
Q2 2022

Jul 11, 2022

BUY
$67.99 - $132.89 $147,130 - $287,573
2,164 Added 306.08%
2,871 $214,000
Q1 2022

Apr 19, 2022

SELL
$94.08 - $130.2 $94 - $130
-1 Reduced 0.14%
707 $362,000
Q4 2021

Feb 04, 2022

BUY
$129.87 - $162.82 $91,947 - $115,276
708 New
708 $380,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Revolve Wealth Partners, LLC Portfolio

Follow Revolve Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Revolve Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Revolve Wealth Partners, LLC with notifications on news.